
TransMedics Group, Inc. (NASDAQ:TMDX) shares are trading lower premarket on Tuesday. On Monday, the company announced the appointment of Gerardo Hernandez as Chief Financial Officer, effective December 2, 2024.
Gerardo Hernandez will be succeeding Stephen Gordon, who will remain with the company as a non-executive employee until March 31, 2025, to ensure a seamless transition.